ACADIA HEALTHCARE CO INC (ACHC) Stock Fundamental Analysis
NASDAQ:ACHC - Nasdaq - US00404A1097 - Common Stock - Currency: USD
Taking everything into account, ACHC scores 4 out of 10 in our fundamental rating. ACHC was compared to 107 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of ACHC while its profitability can be described as average. ACHC is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
ACHC had positive earnings in the past year.
In the past year ACHC had a positive cash flow from operations.
In multiple years ACHC reported negative net income over the last 5 years.
Each year in the past 5 years ACHC had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of 4.29%, ACHC is doing good in the industry, outperforming 75.00% of the companies in the same industry.
ACHC has a better Return On Equity (8.32%) than 72.22% of its industry peers.
The Return On Invested Capital of ACHC (7.51%) is better than 73.15% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ACHC is in line with the industry average of 8.16%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.29% | ||
| ROE | 8.32% | ||
| ROIC | 7.51% |
ROA(3y)3.12%
ROA(5y)0.6%
ROE(3y)5.75%
ROE(5y)-2.11%
ROIC(3y)7.93%
ROIC(5y)7.15%
1.3 Margins
The Profit Margin of ACHC (8.10%) is better than 87.96% of its industry peers.
In the last couple of years the Profit Margin of ACHC has grown nicely.
With an excellent Operating Margin value of 16.56%, ACHC belongs to the best of the industry, outperforming 95.37% of the companies in the same industry.
ACHC's Operating Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.56% | ||
| PM (TTM) | 8.1% | ||
| GM | N/A |
OM growth 3Y-1.13%
OM growth 5Y1.15%
PM growth 3Y-0.53%
PM growth 5Y8.37%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ACHC is destroying value.
The number of shares outstanding for ACHC has been increased compared to 1 year ago.
Compared to 5 years ago, ACHC has more shares outstanding
ACHC has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.50, we must say that ACHC is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.50, ACHC perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
A Debt/Equity ratio of 0.62 indicates that ACHC is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.62, ACHC is in line with its industry, outperforming 54.63% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.5 |
ROIC/WACC0.9
WACC8.34%
2.3 Liquidity
A Current Ratio of 1.00 indicates that ACHC may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.00, ACHC is doing worse than 76.85% of the companies in the same industry.
ACHC has a Quick Ratio of 1.00. This is a bad value and indicates that ACHC is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.99, ACHC is doing worse than 68.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1 | ||
| Quick Ratio | 0.99 |
3. Growth
3.1 Past
ACHC shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.79%.
ACHC shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.21% yearly.
ACHC shows a small growth in Revenue. In the last year, the Revenue has grown by 7.69%.
Measured over the past years, ACHC shows a quite strong growth in Revenue. The Revenue has been growing by 9.45% on average per year.
EPS 1Y (TTM)-3.79%
EPS 3Y8.69%
EPS 5Y10.21%
EPS Q2Q%-24.71%
Revenue 1Y (TTM)7.69%
Revenue growth 3Y10.87%
Revenue growth 5Y9.45%
Sales Q2Q%4.23%
3.2 Future
The Earnings Per Share is expected to grow by 12.93% on average over the next years. This is quite good.
The Revenue is expected to grow by 7.75% on average over the next years.
EPS Next Y3.66%
EPS Next 2Y8.47%
EPS Next 3Y12.93%
EPS Next 5YN/A
Revenue Next Year6.49%
Revenue Next 2Y7.83%
Revenue Next 3Y7.75%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 9.26, the valuation of ACHC can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of ACHC indicates a rather cheap valuation: ACHC is cheaper than 94.44% of the companies listed in the same industry.
ACHC is valuated cheaply when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 8.94, the valuation of ACHC can be described as very reasonable.
ACHC's Price/Forward Earnings ratio is rather cheap when compared to the industry. ACHC is cheaper than 92.59% of the companies in the same industry.
ACHC is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.26 | ||
| Fwd PE | 8.94 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ACHC is valued cheaper than 85.19% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 7.04 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ACHC has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ACHC's earnings are expected to grow with 12.93% in the coming years.
PEG (NY)2.53
PEG (5Y)0.91
EPS Next 2Y8.47%
EPS Next 3Y12.93%
5. Dividend
5.1 Amount
ACHC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
30.57
+0.66 (+2.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners109.62%
Inst Owner Change1.9%
Ins Owners1%
Ins Owner Change0.43%
Market Cap2.84B
Analysts83.16
Price Target54.88 (79.52%)
Short Float %6.39%
Short Ratio3.24
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.73%
Min EPS beat(2)-12.21%
Max EPS beat(2)-1.26%
EPS beat(4)2
Avg EPS beat(4)-2.21%
Min EPS beat(4)-12.21%
Max EPS beat(4)2.44%
EPS beat(8)6
Avg EPS beat(8)0.69%
EPS beat(12)9
Avg EPS beat(12)9.22%
EPS beat(16)11
Avg EPS beat(16)7.41%
Revenue beat(2)0
Avg Revenue beat(2)-2.49%
Min Revenue beat(2)-2.56%
Max Revenue beat(2)-2.42%
Revenue beat(4)0
Avg Revenue beat(4)-2.21%
Min Revenue beat(4)-3.36%
Max Revenue beat(4)-0.51%
Revenue beat(8)3
Avg Revenue beat(8)-0.84%
Revenue beat(12)4
Avg Revenue beat(12)-0.77%
Revenue beat(16)5
Avg Revenue beat(16)-0.74%
PT rev (1m)-11.9%
PT rev (3m)-10.57%
EPS NQ rev (1m)-1.64%
EPS NQ rev (3m)-7.11%
EPS NY rev (1m)-1.07%
EPS NY rev (3m)-6.54%
Revenue NQ rev (1m)-0.25%
Revenue NQ rev (3m)-0.82%
Revenue NY rev (1m)-2.39%
Revenue NY rev (3m)-2.53%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.26 | ||
| Fwd PE | 8.94 | ||
| P/S | 0.9 | ||
| P/FCF | N/A | ||
| P/OCF | 21.9 | ||
| P/B | 0.92 | ||
| P/tB | 3.84 | ||
| EV/EBITDA | 7.04 |
EPS(TTM)3.3
EY10.79%
EPS(NY)3.42
Fwd EY11.19%
FCF(TTM)-6.03
FCFYN/A
OCF(TTM)1.4
OCFY4.57%
SpS33.95
BVpS33.08
TBVpS7.95
PEG (NY)2.53
PEG (5Y)0.91
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.29% | ||
| ROE | 8.32% | ||
| ROCE | 9.71% | ||
| ROIC | 7.51% | ||
| ROICexc | 7.62% | ||
| ROICexgc | 13.61% | ||
| OM | 16.56% | ||
| PM (TTM) | 8.1% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)3.12%
ROA(5y)0.6%
ROE(3y)5.75%
ROE(5y)-2.11%
ROIC(3y)7.93%
ROIC(5y)7.15%
ROICexc(3y)8.08%
ROICexc(5y)7.37%
ROICexgc(3y)16.06%
ROICexgc(5y)14.72%
ROCE(3y)10.25%
ROCE(5y)9.25%
ROICexcg growth 3Y-4.56%
ROICexcg growth 5Y16.02%
ROICexc growth 3Y1.65%
ROICexc growth 5Y14.56%
OM growth 3Y-1.13%
OM growth 5Y1.15%
PM growth 3Y-0.53%
PM growth 5Y8.37%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 2.81 | ||
| Cap/Depr | 461.5% | ||
| Cap/Sales | 21.89% | ||
| Interest Coverage | 4.61 | ||
| Cash Conversion | 19.3% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1 | ||
| Quick Ratio | 0.99 | ||
| Altman-Z | 1.5 |
F-Score5
WACC8.34%
ROIC/WACC0.9
Cap/Depr(3y)344.44%
Cap/Depr(5y)299.77%
Cap/Sales(3y)15.9%
Cap/Sales(5y)13.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.79%
EPS 3Y8.69%
EPS 5Y10.21%
EPS Q2Q%-24.71%
EPS Next Y3.66%
EPS Next 2Y8.47%
EPS Next 3Y12.93%
EPS Next 5YN/A
Revenue 1Y (TTM)7.69%
Revenue growth 3Y10.87%
Revenue growth 5Y9.45%
Sales Q2Q%4.23%
Revenue Next Year6.49%
Revenue Next 2Y7.83%
Revenue Next 3Y7.75%
Revenue Next 5YN/A
EBIT growth 1Y3.11%
EBIT growth 3Y9.61%
EBIT growth 5Y10.7%
EBIT Next Year34.07%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1567.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-71.95%
OCF growth 3Y-29.78%
OCF growth 5Y-15.9%